Earnings Call · Q2 FY2024·2024-07-17

Q2 24EPS +1.10%·Rev n/aQ1 24EPS +1.04%·Rev n/aQ4 23EPS +0.54%·Rev n/aQ3 23EPS +6.26%·Rev n/a⚠ consensus missing

Elevance Health, Inc. ELV

Steve Tanal — Vice President of Investor Relations

Gail Boudreaux — President and CEO

Mark Kaye — Chief Financial Officer

−5.8%1d on move date−4.4% vs SPY3d−9.6%5d−9.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ELV calls or request research access.

More ELV calls Browse calls Request research access